Osel, Inc.   Report issue

For profit Phase 2
Founded: Mountain View CA United States (1996)

Organization Overview

First Clinical Trial
2006
NCT00305227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Osel, Inc.